Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia-Reference-Cited by-同舟云学术

Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia

Published:2020-03 Issue:3 Volume:26 Page:379-386
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Janelidze Shorena^ORCID,Mattsson Niklas,Palmqvist Sebastian,Smith Ruben,Beach Thomas G.,Serrano Geidy E.,Chai Xiyun,Proctor Nicholas K.,Eichenlaub Udo,Zetterberg Henrik,Blennow Kaj,Reiman Eric M.^ORCID,Stomrud Erik,Dage Jeffrey L.,Hansson Oskar^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/s41591-020-0755-1.pdf

Reference46 articles.

1. Jack, C. R. Jr. et al. NIA-AA Research Framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 14, 535–562 (2018).

2. Blennow, K., Hampel, H., Weiner, M. & Zetterberg, H. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat. Rev. Neurol. 6, 131–144 (2010).

3. Mielke, M. M. et al. Plasma phospho-tau181 increases with Alzheimer’s disease clinical severity and is associated with tau- and amyloid-positron emission tomography. Alzheimers Dement. 14, 989–997 (2018).

4. Tatebe, H. et al. Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and Down Syndrome. Mol. Neurodegener. 12, 63 (2017).

5. Yang, C. C. et al. Assay of plasma phosphorylated tau protein (Threonine 181) and total tau protein in early-stage Alzheimer’s disease. J. Alzheimers Dis. 61, 1323–1332 (2018).

Cited by 759 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of Alzheimer's disease plasma biomarkers in the oldest-old: a prospective primary care-based study;The Lancet Regional Health - Europe;2024-10

2. Diagnosis and therapy of Alzheimer's disease: Light-driven heterogeneous redox processes;Advances in Colloid and Interface Science;2024-10

3. GRN knockdown regulates the expression and alternative splicing of genes associated with aphasia-related diseases in PC12 cells;Brain Research;2024-10

4. Navigating the Landscape of Plasma Biomarkers in Alzheimer's Disease: Focus on Past, Present, and Future Clinical Applications;Neurology and Therapy;2024-09-07

5. Alzheimer’s disease biomarkers and their current use in clinical research and practice;Molecular Psychiatry;2024-09-04